SUMMARY Recent studies have noted the limitations of the exercise ECG as a screening test for coronary artery disease (CAD), particularly in asymptomatic patients. To improve the sensitivity and predictive accuracy of noninvasive screening studies, we analyzed the results of using cardiac fluoroscopy (to detect coronary calcifications) in conjunction with electrocardiographic exercise testing to detect CAD. We used these tests to screen patients for participation in the NHLBI Type II Coronary Intervention Study. The predictive accuracy of a positive test for identifying any degree of coronary artery stenosis among asymptomatic patients (n = 93) was 86% for cardiac fluoroscopy and 69% for exercise testing (p = 0.07). However, the predictive accuracy of a positive test for identifying lesons .50% in this same population was only 46% for cardiac fluoroscopy and 36% for exercise testing. The combination of a positive exercise test and positive cardiac fluoroscopy increased the predictive accuracy for lesions .50% to 82% (p < 0.05). Among symptomatic patients (n = 61), sensitivity for detecting lesions .50% increased from 40% for electrocardiographic exercise testing alone to 65% when fluoroscopic results were also considered. We conclude that either test used alone has a low predictive accuracy for detecting lesions .50% in asymptomatic subjects and a low sensitivity in symptomatic subjects. However, 1) predictive accuracy is significantly improved in asymptomatic type II patients when both tests are positive; 2) sensitivity for detecting lesions >50% in symptomatic type 11 patients is enhanced significantly by a combination of two tests rather than either one alone; and 3) the presence of coronary calcifications indicates some level of underlying coronary disease with a high predictive accuracy (86% We undertook this prospective study 1) to evaluate fluoroscopic detection of coronary calcifications as a screening test for CAD, 2) to compare the results of fluoroscopy with those of electrocardiographic exercise testing, and 3) to determine whether combining the results of the fluoroscopic determination of coronary calcifications with electrocardiographic response to exercise enhances the sensitivity and predictive accuracy for detection of CAD.
RECENTLY, considerable attention has been focused on the need for a reliable noninvasive test to identify subjects with coronary artery disease (CAD). At the start of the National Heart, Lung, and Blood Institute's Type II Coronary Intervention program in 1971, the only commonly used screening test was the exercise ECG. However, because of the reported pathologicl-6 and clinical relation7 1' between calcium in the cordnary arteries and coronary atheroma, we chose to use fluoroscopy to evaluate the presence of coronary calcification and the exercise test as screening procedures for CAD in our patient population. Since then, reports have established a positive relation between the presence of calcium on fluoroscopy and angiographically demonstrated CAD in symptomatic patients.7 "I None of these studies, however, used fluoroscopy as a screening test for CAD in an asymptomatic population, or determined (when possible) its predictive accuracy, specificity, or sensitivity in asymptomatic vs symptomatic patients with angiographically identified CAD. cumulated indicating that more than half of the asymptomatic patients with positive electrocardiographic responses to exercise have coronary arteries that are either normal or only minimally narrowed, as determined by coronary angiography.'l 17, 19 In addition, a relatively high percentage of asymptomatic and symptomatic patients with CAD have a negative electrocardiographic response to exercise. [18] [19] [20] [21] [22] [23] [24] We undertook this prospective study 1) to evaluate fluoroscopic detection of coronary calcifications as a screening test for CAD, 2) to compare the results of fluoroscopy with those of electrocardiographic exercise testing, and 3) to determine whether combining the results of the fluoroscopic determination of coronary calcifications with electrocardiographic response to exercise enhances the sensitivity and predictive accuracy for detection of CAD.
Methods

Patient Population
All patients were referred to the National Heart, Lung, and Blood Institute for evaluation of an elevated cholesterol level and for possible participation in the Institute's Coronary Intervention Study. This study is a prospective, randomized, double-blind trial of the effect of a cholesterol-lowering regimen on the progression of angiographically demonstrable CAD. All patients had LDL cholesterol above the 90th percentile for age after 1 month of dietary therapy (All subjects were thoroughly instructed in a diet designed to limit daily cholesterol intake to less than 300 mg and result in a polyunsaturated-tosaturated fat ratio of 2:1.); no laboratory or clinical evidence of hepatic, renal, or thyroid disease; fasting triglycerides <400 mg/100 ml; resting blood pressure <160/100 mm Hg; fasting blood sugar values <130 mg/l00 ml; no congestive heart failure or severe, medically intractable angina; and no patient was taking any medications known to affect serum lipoprotein levels. Fully informed consent was obtained, and patients underwent coronary angiography only if they had both an elevated LDL cholesterol after following the type II diet for 1 To assess intraobserver reproducibility, we examined the results of fluoroscopy done 3 months apart by the same radiologists. For the first reading, the radiologist was blinded and had no previous knowledge of the patient or his or her data; for the second reading, the radiologist did not know the results of the first reading, the patient was instructed not to tell him, and the chart was not readily available. We analyzed 157 of these readings: 139 (89%) were exactly reproduced both readings showed calcification in 76 and no calcification in 63. Nine readings that originally showed calcification were reversed, as were nine readings that originally showed no calcification.
Exercise Test
The electrocardiographic response to exercise was determined during the upright bicycle ergometry with two training sessions preceding the final test. We increased the workload by 20-watt increments every 3 minutes until angina developed or until heart rate reached 85% of the predicted maximum for the subject's age and sex. We chose the initial workload so that the total duration of exercise was 3-8 minuteslong enough to allow a relatively steady state to be achieved but short enough to obviate the confounding effects of fatigue. Electrocardiographic leads were arranged in a modified CM5 system with a reference electrode over the manubrium, an exploring electrode in the V5 position to assess ST-segment and T-wave changes with a horizontal vector, and a second exploring electrode over the lumbar spine to assess STsegment and T-wave changes with an inferior vector. We recorded the ECG continuously during exercise and for 5 minutes thereafter.
Serum electrolytes were normal at the time of exercise (K+ values 3.5-5.5 mEq/l). The mean exercise time was 4.0 minutes and the mean initial work load was 120 watts. 170 patients exercised to 85% of predicted maximal heart rate, seven exercised to angina, two were stopped because of serious arrhythmias and two because of fatigue. The mean heart rate after exercise was 145 beats/min.
An exercise ECG was considered positive if, 0.08 second after the J point, the ST 
Sensitivity
The sensitivity (the frequency of a positive test in a group of patients having disease) of fluoroscopy and the electrocardiographic exercise test for detecting CAD was calculated for the symptomatic patients ( fig.  3 ). We could not calculate sensitivity for asymptomatic subjects because subjects with no symptoms and negative fluoroscopic and exercise tests were not studied by angiography.
Patients with >50% coronary artery narrowing. In the 48 symptomatic subjects (typical angina, prior myocardial infarction or both) who had one or more coronary stenoses that produced narrowing >50%, fluoroscopy was positive in 46% and exercise testing was positive in 40% (NS).
Patients with any degree ofcoronary artery narrowing. In the 54 symptomatic patients who had any degree of coronary artery narrowing, fluoroscopy was positive in 43% and exercise testing was positive in 35% (NS). Exercise Tests with Angiography (table 2) Predictive Accuracy
Correlation of Combined Results of Fluoroscopy and
Patients with coronary artery narrowing >50%. .001) (fig. 4) . Predictive accuracy was already 95% in the symptomatic subjects with a positive electrocardiographic stress test before fluoroscopy and, therefore, could not be significantly improved.
Patients with any degree of coronary artery narrowing. As shown in figure 4 , the trend for detecting any CAD is the same as for detecting narrowing >50%.
Sensitivity
As previously mentioned, the sensitivity for detecting existing CAD was calculated only among symptomatic patients and those with atypical angina because asymptomatic subjects with a negative fluoroscopic examination and exercise test were not studied by angiography.
Patients with coronary artery narrowing >50%. Among the 48 subjects in the symptomatic group (typical angina or prior myocardial infarction) with one or more lesions producing coronary artery narrowing >50%, 21% (10 of 48) had both fluoroscopic and exercise tests positive. However, 65% As several studies have noted,'6' 25, 26 the variation in predictive accuracy among different subgroups of patients shown in this study is best explained by Bayes' theorem, which states that when the specificity and sensitivity of a test are < 100%, the predictive accuracy of that test is proportional to the prevalence of the disease in the population under study. Bayes' theorem and our experimental results make clear the diagnostic inadequacy of a less-than-perfect single test in detecting CAD in a population of subjects with low disease prevalence, as is certainly the case with subjects who have no symptoms. Although the prevalence of CAD in patients with atypical chest pain has been reported to be 50% or higher,27 more recent studies28-31 suggest that it is considerably lower. This finding (and the small number of patients studied in this subgroup) probably explains the low predictive accuracy of fluoroscopy and electrocardiographic exercise testing in patients with atypical angina.
Because both fluoroscopy and exercise electrocardiography when used alone manifest important limitations in predictive accuracy for detecting coronary narrowing .50%, we assessed the efficacy of a combination of the two methods. These results are summarized in figures 5 and 6. Among asymptomatic subjects, the chance of finding narrowing . 50% is markedly improved when both screening tests are positive. Thus, when a positive electrocardiographic stress test alone was considered, only 36% of patients had narrowing >50%. However, 82% had narrowing .50% when both tests were positive. A positive result on both screening tests also greatly increased a patient's chance of having three or more lesions . 50% ( fig. 6 ).
The value of combining the two tests is more limited in symptomatic patients ( fig. 5 ), since 90% have coronary artery narrowing .50%, even if only one of the two tests is positive. However, a negative result on both tests significantly (p < 0.01) decreases the likelihood of coronary lesions >50%, and a combined positive result increases the likelihood of multivessel disease.
The combination of fluoroscopic examination and electrocardiographic exercise testing enhances the predictive accuracy for detecting coronary narrowing >50%. However, the requirement that both tests be positive to screen for CAD necessarily diminishes an already low sensitivity. Thus, of our asymptomatic patients with coronary narrowing .50%, 46% had a positive fluoroscopic examination and 36% had a positive electrocardiographic exercise test, but in only 21% were both tests positive.
Although fluoroscopic examination and exercise testing appear to be of limited value in improving the detection of significant coronary disease in symptomatic patients, our data suggest that in combination they can considerably enhance the detection of coronary lesions .50% in asymptomatic patients ( fig.   8 ). Thirty-nine of our asymptomatic patients had a positive electrocardiographic exercise test, but only 14 Although fluoroscopy is a relatively poor predictor of coronary stenosis .50% in asymptomatic subjects, it appears to be a particularly good predictor of coronary artery abnormalities when the range of severity includes any irregularity in a vessel wall. Thus, of the 65 asymptomatic subjects who had coronary calcifications observed at fluoroscopy, 86% had some degree of coronary narrowing on angiographic study. Although the clinical value of such information is unclear, it is likely that the presence of even clinically insignificant lesions identifies a group of patients at higher risk of developing future coronary events.32 35 The combination of exercise-induced ST-segment abnormalities and detection of coronary calcifications permits some separation between patients with threevessel coronary artery narrowing .50% and those with less severe disease. Among the entire study group of 181 patients, 25 had both a positive fluoroscopy and a positive electrocardiographic exercise test. Fortyeight percent of these (12 of 25) had three-vessel disease by angiography. In contrast, only 12% (19 of 156) of patients with only one or neither test positive had three-vessel disease by angiography. The results of the analysis of combined abnormalities were similar when the asymptomatic and symptomatic patients were evaluated separately.
When calcium is seen by fluoroscopy, there is a close correlation between the location of calcium and (table 3) . The poor correlation noted with the left main coronary artery probably results from the short length of this vessel, the difficulty in identifying its location fluoroscopically, and its proximity to the aortic valve which itself may be calcified. However, despite its usefulness in the localization of disease, the amount of calcium detected by fluoroscopy was not proportional to the anatomical severity of disease.
It may be argued that our patients are a specially selected subgroup, and therefore the relevance of data derived from these patients to data from other patients with CAD is questionable. Such an argument, however, neglects the fact that the patient population of any study from any institution must be selected. Therefore few, if any, clinical studies are immune from the criticism that the results derived cannot with certainty be applied to the "general patient population."
Several points also should be made regarding the distinct characteristics of our patient population, and whether these patients can be considered more or less relevant than patients in other studies. The ratio of men to women and the amount of coronary disease in our study population were comparable to those in many studies. Our population appears to be unusual in that all of our patients had hyperlipidemia, were less than 55 years of age, did not have hypertension or diabetes, and most had fewer clinical symptoms than the patients included in studies from large referral centers. However, many patients reported from other centers have elevated serum cholesterol, and it would be difficult to argue that the results of a well-defined, younger (mean age 46 years) series of patients with elevated serum cholesterol levels and no hypertension or diabetes are not clinically relevant.
Moreover, as noted above, although our patient population is a selected one, so is the population, by necessity, of any clinical study. Unfortunately, the selection factors influencing most of our current data based on patients with coronary disease derive from the populations of large cardiac centers to which patients who are more severely symptomatic and more difficult to manage are usually referred. We studied asymptomatic and mildly to moderately symptomatic patients, a fact which suggests that our population may be more representative of the patients seen in clinical practice than populations of other studies. Moreover, our patients were selected primarily because they had a cholesterol problem (not a coronary problem) and are, therefore, more likely to represent the full spectrum of coronary disease than patients reported in studies where a requirement for referral is usually a problem that the primary care physician feels should be handled by a large referral center. Most of our patients came from community screening or surveillance programs, and the criterion of admission was an elevated cholesterol level. Therefore, our patients were not more highly selected than patients studied at other referral centers. For all of the above reasons, our patient population is just as appropriate for testing the reliability of noninvasive diagnostic techniques as the highly selected populations used traditionally. The information derived from our patients would be as "relevant" as and subject to less bias than that obtained from the usual, less well-defined referral populations.
In summary, these results demonstrate that detection of coronary artery calcifications by fluoroscopy in hyperlipidemic type II subjects 55 years of age or less, is highly correlated with the presence of some degree of CAD. Although neither detection of calcium nor the demonstration of ST-segment depression >1 mm alone reliably predicts coronary artery narrowing .50% in asymptomatic patients, the combination of coronary calcifications and an abnormal electrocardiographic response to exercise has a higher predictive accuracy and helps in identifying the presence of significant three-vessel coronary disease. The limitation of this approach, however, is that predictive accuracy is enhanced at the expense of diagnostic sensitivity.
classification rates, rather than to identify patients predicted to die; these have used historical and clinical7 12, 13 or hemodynamic data'4 or both. 8 The present investigation, directed toward predicting death or survival in the individual patient, is a retrospective study of patients with acute myocardial infarction who were carefully characterized by clinical and objective noninvasive measurements and in many instances by hemodynamic data as well. Risk factors were identified and used multivariately to predict early and late mortality by means of stepwise linear discriminant analysis. The approach could identify soon after hospital admission patients who would die within 1 month and those who would survive. We validated the methodology by determining confidence limits for the classification rates in the original population, applying the initial functions to a subsequent population, and testing the reliability of the general approach in the combined population using two randomized samples.
Methods
The initial population of 224 patients with acute myocardial infarction (77% males and 23% females, mean age 59.6 years) was studied between July 1969 1124
